Cancer

NeoGenomics Launches PanTracer Pro for Solid Tumor Testing

The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.

Cancer

Ambry Genetics Expands MAVE Research to PALB2 Gene for Hereditary Cancer Testing

Ambry Genetics supported a new study evaluating 6,718 PALB2 gene variants using MAVEs, advancing risk assessment for hereditary breast and pancreatic cancer.

Cancer

Researchers Identify Four New Markers for Detecting Aggressive Breast Cancer Cells in Blood

Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.

Daisy Genomics, New Day Diagnostics Partner on Colorectal Cancer Detection Platform

Jan 9, 2026 | Colorectal

The collaboration will combine New Day’s liquid biopsy technology with Daisy Genomics’ physics-based sequencing platform to advance early CRC screening.

InterVenn Partners with Aranscia to Expand Ovarian Cancer Test Access

Jan 8, 2026 | Cancer

Multi-year agreement will provide clinical workflow software and laboratory support for GlycoKnow liquid biopsy test.

HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection

Jan 7, 2026 | Cervical (HPV)

New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.

Human Longevity Expands $1M Cancer Pledge to Include Colon Cancer

Dec 31, 2025 | Colorectal

The biotechnology company’s integrated screening approach combines whole-genome sequencing, imaging, and multiple biomarker tests to enable early detection.

PreciseDx Presents Validation Data for AI Breast Cancer Recurrence Test

Dec 29, 2025 | Breast

Three abstracts showcase PreciseBreast’s ability to predict recurrence risk in early-stage invasive breast cancer using digital pathology.

Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend

Dec 24, 2025 | Cervical (HPV)

Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.

AI Pathology Solution Shows Concordance with Pathologists in HER2 Interpretation for Biliary Tract Cancer

Dec 23, 2025 | Cancer

Study in biliary tract cancer finds the solution achieved 83.5% overall concordance rate with expert interpretations.

CTC Counts Show Value in Guiding Metastatic Breast Cancer Treatment Decisions

Dec 22, 2025 | Breast

Researchers found that circulating tumor cell counts stratified patients by disease aggressiveness and were associated with differing outcomes following endocrine versus combination therapy.

Genomic Test Shows Promise for Identifying High-Risk Prostate Cancer in African American Men

Dec 22, 2025 | Prostate

A genomic test widely used in prostate cancer care can more accurately identify which men with early-stage disease face high risk of recurrence after treatment.

Reducing the Cost of Cancer Care with Improved Diagnostics

Dec 22, 2025 | Cancer

Better cancer testing can help patients avoid unnecessary scans and biopsies, while also lowering costs for the healthcare system.

Yenos Analytical Launches Multi-Cancer Early Detection Urine Test

Dec 19, 2025 | Cancer, Company News, Molecular Diagnostics

The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.